Mercer Global Advisors’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-26
| Closed | -$4K | – | 2027 |
|
|
2022
Q4 | $4K | Hold |
26
| – | – | ﹤0.01% | 1923 |
|
|
2022
Q3 | $13K | Sell |
26
-1
| -4% | -$500 | ﹤0.01% | 1802 |
|
|
2022
Q2 | $23K | Hold |
27
| – | – | ﹤0.01% | 1796 |
|
|
2022
Q1 | $67K | Hold |
27
| – | – | ﹤0.01% | 1819 |
|
|
2021
Q4 | $69K | Buy |
27
+1
| +4% | +$2.56K | ﹤0.01% | 1735 |
|
|
2021
Q3 | $119K | Hold |
26
| – | – | ﹤0.01% | 1669 |
|
|
2021
Q2 | $179K | Hold |
26
| – | – | ﹤0.01% | 1583 |
|
|
2021
Q1 | $191K | Hold |
26
| – | – | ﹤0.01% | 1491 |
|
|
2020
Q4 | $211K | Hold |
26
| – | – | ﹤0.01% | 1217 |
|
|
2020
Q3 | $266K | Buy |
+26
| New | +$266K | ﹤0.01% | 1007 |
|